• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自大岛研究的作为连续变量的血压白大衣效应的长期再现性。

The long-term reproducibility of the white-coat effect on blood pressure as a continuous variable from the Ohasama Study.

作者信息

Satoh Michihiro, Yoshida Tomoya, Metoki Hirohito, Murakami Takahisa, Tatsumi Yukako, Hirose Takuo, Takabatake Kyosuke, Tsubota-Utsugi Megumi, Hara Azusa, Nomura Kyoko, Asayama Kei, Kikuya Masahiro, Hozawa Atsushi, Imai Yutaka, Ohkubo Takayoshi

机构信息

Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-Ku, Sendai, Miyagi, 983-8536, Japan.

Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

出版信息

Sci Rep. 2023 Mar 27;13(1):4985. doi: 10.1038/s41598-023-31861-9.

DOI:10.1038/s41598-023-31861-9
PMID:36973366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10043024/
Abstract

There is little information about the reproducibility of the white coat effect, which was treated as a continuous variable. To investigate a long-term interval reproducibility of the white-coat effect as a continuous variable. We selected 153 participants without antihypertensive treatment (men, 22.9%; age, 64.4 years) from the general population of Ohasama, Japan, to assess the repeatedly measured white-coat effect (the difference between blood pressures at the office and home) in a 4-year interval. The reproducibility was assessed by testing the intraclass correlation coefficient (two-way random effect model-single measures). The white-coat effect for systolic/diastolic blood pressure slightly decreased by 0.17/1.56 mmHg at the 4-year visit on average. The Bland-Altman plots showed no significant systemic error for the white-coat effects (P ≥ 0.24). The intraclass correlation coefficient (95% confidence interval) of the white-coat effect for systolic blood pressure, office systolic blood pressure, and home systolic blood pressure were 0.41 (0.27-0.53), 0.64 (0.52-0.74), and 0.74 (0.47-0.86), respectively. Change in the white-coat effect was mainly affected by a change in office blood pressure. Long-term reproducibility of the white-coat effect is limited in the general population without antihypertensive treatment. The change in the white-coat effect is mainly caused by office blood pressure variation.

摘要

关于被视为连续变量的白大衣效应的可重复性,相关信息较少。为了研究作为连续变量的白大衣效应的长期间隔可重复性。我们从日本大岛的普通人群中选取了153名未接受抗高血压治疗的参与者(男性占22.9%;年龄为64.4岁),以评估4年间隔内重复测量的白大衣效应(诊室血压与家庭血压之间的差值)。通过测试组内相关系数(双向随机效应模型 - 单次测量)来评估可重复性。在4年随访时,收缩压/舒张压的白大衣效应平均略有下降,分别下降了0.17/1.56 mmHg。Bland - Altman图显示白大衣效应无显著的系统误差(P≥0.24)。收缩压的白大衣效应、诊室收缩压和家庭收缩压的组内相关系数(95%置信区间)分别为0.41(0.27 - 0.53)、0.64(0.52 - 0.74)和0.74(0.47 - 0.86)。白大衣效应的变化主要受诊室血压变化的影响。在未接受抗高血压治疗的普通人群中,白大衣效应的长期可重复性有限。白大衣效应的变化主要由诊室血压波动引起。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10043024/eaf323900f4f/41598_2023_31861_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10043024/1c2f22ade19f/41598_2023_31861_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10043024/eaf323900f4f/41598_2023_31861_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10043024/1c2f22ade19f/41598_2023_31861_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10043024/eaf323900f4f/41598_2023_31861_Fig2_HTML.jpg

相似文献

1
The long-term reproducibility of the white-coat effect on blood pressure as a continuous variable from the Ohasama Study.来自大岛研究的作为连续变量的血压白大衣效应的长期再现性。
Sci Rep. 2023 Mar 27;13(1):4985. doi: 10.1038/s41598-023-31861-9.
2
Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.白大衣抵抗性高血压患者重复动态血压监测的适当时间间隔。
Hypertension. 2012 Feb;59(2):384-9. doi: 10.1161/HYPERTENSIONAHA.111.185405. Epub 2012 Jan 3.
3
Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study.根据早晚家庭血压值的平均值定义的隐匿性未控制和治疗的白大衣高血压患病率:来自日本家庭与办公室测量评估研究。
Blood Press Monit. 2005 Dec;10(6):311-6. doi: 10.1097/00126097-200512000-00005.
4
Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.反向白大衣效应作为已治疗高血压患者微量白蛋白尿的独立危险因素。
Nephrol Dial Transplant. 2007 Mar;22(3):911-6. doi: 10.1093/ndt/gfl642. Epub 2006 Dec 1.
5
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].老年患者中难以控制的动脉高血压。“白大衣效应”的意义
Rev Port Cardiol. 1999 Oct;18(10):897-906.
6
Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study.基于家庭和动态血压测量的部分白大衣或隐匿性高血压导致的长期卒中风险:大崎研究
Hypertension. 2016 Jan;67(1):48-55. doi: 10.1161/HYPERTENSIONAHA.115.06461. Epub 2015 Nov 2.
7
Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.强化与标准诊室高血压治疗策略对白衣效应和隐匿性未控制高血压的影响:来自 SPRINT 动态血压监测辅助研究。
Hypertension. 2020 Oct;76(4):1090-1096. doi: 10.1161/HYPERTENSIONAHA.120.15300. Epub 2020 Aug 24.
8
Assessment of the white-coat effect among hypertensive patients presumed to be at goal.评估被认为已达标的高血压患者中的白大衣效应。
Ann Pharmacother. 2011 Jul;45(7-8):910-5. doi: 10.1345/aph.1P771. Epub 2011 Jul 12.
9
Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.动态血压监测与真性及白大衣抵抗性高血压的临床特征
Clin Exp Hypertens. 2001 Apr;23(3):203-11. doi: 10.1081/ceh-100102660.
10
Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.白大衣性高血压和隐蔽性高血压的预后:与心血管结局相关的家庭血压国际数据库。
Hypertension. 2014 Apr;63(4):675-82. doi: 10.1161/HYPERTENSIONAHA.113.02741. Epub 2014 Jan 13.

引用本文的文献

1
Association between urinary sodium-to-potassium ratio and BNP in a general population without antihypertensive treatment and cardiovascular diseases: the Ohasama study.无抗高血压治疗及心血管疾病的普通人群中尿钠钾比值与脑钠肽的关联:大岛研究
Hypertens Res. 2025 Jun 27. doi: 10.1038/s41440-025-02266-0.
2
Home blood pressure control and prescribing patterns of anti-hypertensive medications in a home blood pressure-based hypertension-specialized clinic in Japan: a sub-analysis of the Ohasama study.日本一家基于家庭血压的高血压专科诊所的家庭血压控制及抗高血压药物处方模式:大崎研究的子分析
Hypertens Res. 2025 Jan;48(1):26-36. doi: 10.1038/s41440-024-01954-7. Epub 2024 Oct 28.

本文引用的文献

1
Reproducibility of masked hypertension and office-based hypertension: a systematic review and meta-analysis.掩蔽性高血压和诊室高血压的可重复性:系统评价和荟萃分析。
J Hypertens. 2022 Jun 1;40(6):1053-1059. doi: 10.1097/HJH.0000000000003111.
2
Prediction Models for the 5- and 10-Year Incidence of Home Morning Hypertension: The Ohasama Study.家庭清晨高血压 5 年和 10 年发生率的预测模型:大盐研究。
Am J Hypertens. 2022 Apr 2;35(4):328-336. doi: 10.1093/ajh/hpab177.
3
Direct comparison of the reproducibility of in-office and self-measured home blood pressures.
诊室血压与家庭自我测量血压可重复性的直接比较。
J Hypertens. 2022 Feb 1;40(2):398-407. doi: 10.1097/HJH.0000000000003026.
4
2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement.2021年欧洲高血压学会诊室和诊室外血压测量实践指南。
J Hypertens. 2021 Jul 1;39(7):1293-1302. doi: 10.1097/HJH.0000000000002843.
5
Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension.动态血压监测在高血压诊断和管理中的应用。
Hypertension. 2021 Feb;77(2):254-264. doi: 10.1161/HYPERTENSIONAHA.120.14591. Epub 2021 Jan 4.
6
Limited reproducibility of MUCH and WUCH: evidence from the ELSA study.MUCH和WUCH的可重复性有限:来自ELSA研究的证据。
Eur Heart J. 2020 Apr 21;41(16):1565-1571. doi: 10.1093/eurheartj/ehz651.
7
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).日本高血压学会高血压管理指南(JSH 2019)。
Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9.
8
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT.SPRINT 研究中强化和标准临床高血压管理对诊所血压与动态血压及血压变异性一致性的影响。
J Am Heart Assoc. 2019 Jul 16;8(14):e011706. doi: 10.1161/JAHA.118.011706. Epub 2019 Jul 15.
9
Reproducibility of masked uncontrolled hypertension detected through home blood pressure monitoring.通过家庭血压监测检测到的掩蔽性未控制高血压的可重复性。
J Clin Hypertens (Greenwich). 2019 Jul;21(7):877-883. doi: 10.1111/jch.13596. Epub 2019 Jun 19.
10
Blood pressure phenotype reproducibility in CKD outpatients: a clinical practice report.慢性肾脏病门诊患者血压表型的再现性:一份临床实践报告。
Intern Emerg Med. 2020 Jan;15(1):87-93. doi: 10.1007/s11739-019-02127-y. Epub 2019 Jun 17.